Invesco DWA Industrials Momentum ETF News

Wall Street wrapped up the first quarter with a big bang, driven by strong corporate profits, enthusiasm around AI and hopes that the Fed will cut rates.

There is a shift towards a more inclusive approach to stock market investments, helped by a promising economic outlook and supportive monetary policies. Somewhat ebbing AI mania and regulatory woes pr

Designed to provide broad exposure to the Industrials - Broad segment of the equity market, the Invesco Dorsey Wright Industrials Momentum ETF (PRN) is a passively managed exchange traded fund launche

Given the bullishness, many ETFs, having a solid Zacks ETF Rank #1 (Strong Buy) or 2 (Buy), touched new 52-week high and are expected to soar further.

PRN is an ETF that invests in industrial companies with strong momentum characteristics. The Purchasing Managers Index suggests a potential tailwind for the industrials sector in 2024. Supply chain bo

PRN has an index-based strategy designed to benefit from industrial stocks that have been demonstrating significant momentum. I am skeptical about PRN as it was unable to beat either PSCI or XLI over

A total of nine funds launched during the week ending Sept. 1, thus a dip after the 17 ETF launches last week but not unusual in the leadup to a holiday weekend.

Here are a few zones and their ETFs that could potentially experience the positive effects of a hawkish Fed.

Packaging stock Graphic Packaging is near a buy point ahead of earnings. Stellar earnings and technical ratings support the stock.

TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets cu

Profound Medical Corp. (NASDAQ:PROF ) Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Stephen Kilmer - IR Dr. Arun Menawat - CEO Rashed Dewan - CFO Conference Call Par

TORONTO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets cu

TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets c

The manufacturing sector continues to be plagued by supply chain problems while demand is weakening. A post-pandemic reshuffle is in the making, with demand weakening and supply becoming less disrupte

TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets c